You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.
How AI may affect biotech patents
While planning a road trip earlier this year, I discovered that there is a museum that houses old patent models in Wilmington, Del. The U.S. patent office used to require physical models of new inventions until it got too unwieldy to store all of them. In 1880, the patent office switched to requiring diagrams instead.
AI is now changing the intellectual property landscape even further. From questions about whether AI can be an inventor and hold a patent to what “a person skilled in the art” might reasonably know, there are a lot of still-to-be-determined issues that Foley Hoag biotech patent lawyer DeAnn Smith is looking forward to seeing worked out in future litigation.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
